Literature DB >> 2890546

Reduction of gastric acidity with ranitidine or famotidine: early evening dosage is more effective than late evening dosage.

P Bauerfeind1, T Cilluffo, C Emde, C Fimmel, W Kohler, T Gasser, A L Blum.   

Abstract

The antisecretory effect of a once daily dose of ranitidine and famotidine was examined after administration of the drugs either immediately after dinner or 3 h after dinner. A placebo-controlled multiple cross-over study was performed in 7 healthy ambulatory volunteers. They were given, on 6 separate days at least 1 week apart, either placebo, ranitidine 300 mg or famotidine 40 mg, either immediately after dinner or 3 h later. Breakfast, lunch and dinner were standardized. 24-Hour intragastric acidity was measured with a combined glass electrode. Duration of secretory inhibition by a drug was defined as the nighttime period between the first rise of pH above and the final fall below 3.5. This value represents the 95% upper confidence limit of nighttime pH values during placebo treatment. Secretory inhibition with early and late administration of ranitidine lasted for 10.7 and 7.3 h, respectively (p = 0.012). With famotidine it lasted for 10.1 and 7.1 h, respectively (p = 0.005). Gastric acidity after dinner was decreased by early but not late intake of ranitidine and famotidine. Thus, both ranitidine and famotidine were more effective when taken early, immediately after dinner, than when taken late in the evening. This observation might affect the mode of ulcer treatment with these drugs.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2890546     DOI: 10.1159/000199504

Source DB:  PubMed          Journal:  Digestion        ISSN: 0012-2823            Impact factor:   3.216


  7 in total

1.  Frequent non-response to histamine H2-receptor antagonists in cirrhotics.

Authors:  S Walker; D R Krishna; U Klotz; J C Bode
Journal:  Gut       Date:  1989-08       Impact factor: 23.059

Review 2.  Famotidine. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in peptic ulcer disease and other allied diseases.

Authors:  H D Langtry; S M Grant; K L Goa
Journal:  Drugs       Date:  1989-10       Impact factor: 9.546

3.  A comparison of the effects on intragastric acidity of bedtime or dinnertime administration of a once daily dose of famotidine.

Authors:  V Savarino; G S Mela; P Scalabrini; G Fera; P Zentilin; A Sumberaz; G Celle
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

Review 4.  Ranitidine. An updated review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in peptic ulcer disease and other allied diseases.

Authors:  S M Grant; H D Langtry; R N Brogden
Journal:  Drugs       Date:  1989-06       Impact factor: 9.546

5.  Circadian pattern of intragastric acidity in duodenal ulcer patients: a study of variations in relation to ulcer activity.

Authors:  S Wagner; U Gladziwa; M Gebel; A Schüler; J Freise; F W Schmidt
Journal:  Gut       Date:  1991-10       Impact factor: 23.059

6.  Early evening dosing of ranitidine. Comparison with nighttime dosing of ranitidine or cimetidine in duodenal ulceration.

Authors:  J S Dixon; R S Ehsanullah; J G Mills; J R Wood
Journal:  Dig Dis Sci       Date:  1993-08       Impact factor: 3.199

Review 7.  pH, healing rate, and symptom relief in patients with GERD.

Authors:  J Q Huang; R H Hunt
Journal:  Yale J Biol Med       Date:  1999 Mar-Jun
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.